Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 7989

1.

State of the Art Review of the Right Ventricle in COPD Patients: It is Time to Look Closer.

Tannus-Silva DG, Rabahi MF.

Lung. 2016 Dec 3. [Epub ahead of print] Review.

PMID:
27915422
2.

Inhaled Gene Transfer for Pulmonary Circulation.

Aguero J, Hadri L, Hammoudi N, Leonardson L, Hajjar RJ, Ishikawa K.

Methods Mol Biol. 2017;1521:339-349.

PMID:
27910061
3.

Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.

Xu XQ, Lv ZC, Liu QQ, Zhao QH, Wu Y, Sun K, Jiang X, Wang L, Peng FH, Jing ZC.

Int J Cardiol. 2016 Nov 7;228:895-899. doi: 10.1016/j.ijcard.2016.11.036. [Epub ahead of print]

PMID:
27894061
4.

Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?

Thurnheer R, Ulrich S, Bloch KE.

Respiration. 2016 Nov 25. [Epub ahead of print]

PMID:
27884004
5.

Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.

Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA, Howard LS, Kiely DG, Peacock AJ, Pepke-Zaba J, Toshner M, Wort SJ, Gibbs JS, Lawrie A, Gräf S, Morrell NW, Wilkins MR.

Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602. [Epub ahead of print]

PMID:
27881557
6.

Atherosclerotic Renal Artery Stenosis.

Schoepe R, McQuillan S, Valsan D, Teehan G.

Adv Exp Med Biol. 2016 Nov 22. [Epub ahead of print]

PMID:
27873231
7.

Pathophysiological Trends During Withdrawal of Life Support: Implications for Organ Donation After Circulatory Death.

Iyer A, Chew HC, Gao L, Villanueva J, Hicks M, Doyle A, Kumarasinghe G, Jabbour A, Jansz PC, Feneley MP, Harvey RP, Graham RM, Dhital KK, Macdonald PS.

Transplantation. 2016 Dec;100(12):2621-2629.

PMID:
27861290
8.

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers.

Schlosser K, Hanson J, Villeneuve PJ, Dimitroulakos J, McIntyre L, Pilote L, Stewart DJ.

Sci Rep. 2016 Nov 18;6:36596. doi: 10.1038/srep36596.

9.

In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan based Formulation for Dry Powder Inhaler.

Mali AJ, Bothiraja C, Purohit RR, Pawar AP.

Curr Drug Deliv. 2016 Nov 9. [Epub ahead of print]

PMID:
27834151
10.

Pulmonary Arterial Hypertension and the Sex Hormone Paradox.

Foderaro A, Ventetuolo CE.

Curr Hypertens Rep. 2016 Nov;18(11):84. Review.

PMID:
27832457
11.

Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.

Mahmoodi BK, Cushman M, Næss IA, Allison MA, Bos WJ, Brækkan SK, Cannegieter S, Gansevoort RT, Gona PN, Hammerstrøm J, Hansen JB, Heckbert S, Holst AG, Lakoski SG, Lutsey PL, Manson JE, Martin LW, Matsushita K, Meijer K, Overvad K, Prescott EB, Puurunen MK, Rossouw J, Sang Y, Severinsen MT, Ten Berg JM, Folsom AR, Zakai NA.

Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507. [Epub ahead of print]

PMID:
27831499
12.

Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects.

Khaddaj-Mallat R, Morin C, Rousseau É.

Eur J Pharmacol. 2016 Dec 5;792:70-77. doi: 10.1016/j.ejphar.2016.10.038. Review.

PMID:
27818127
13.

Clinical usefulness of end-tidal CO<sub>2</sub> profiles during incremental exercise in patients with chronic thromboembolic pulmonary hypertension.

Ramos RP, Ferreira EV, Valois FM, Cepeda A, Messina CM, Oliveira RK, Araújo AT, Teles CA, Neder JA, Nery LE, Ota-Arakaki JS.

Respir Med. 2016 Nov;120:70-77. doi: 10.1016/j.rmed.2016.09.020.

PMID:
27817818
14.

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

Ghigna MR, Guignabert C, Montani D, Girerd B, Jaïs X, Savale L, Hervé P, Thomas de Montpréville V, Mercier O, Sitbon O, Soubrier F, Fadel E, Simonneau G, Humbert M, Dorfmüller P.

Eur Respir J. 2016 Dec;48(6):1668-1681. doi: 10.1183/13993003.00464-2016.

PMID:
27811071
15.

Predictors of residual pulmonary hypertension after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Tsuji A, Ogo T, Ueda J, Fukui S, Morita Y, Fukuda T, Nakanishi N, Ogawa H, Yasuda S.

Int J Cardiol. 2017 Jan 1;226:118-120. doi: 10.1016/j.ijcard.2016.09.132. No abstract available.

PMID:
27810474
16.

Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension.

Zhang R, Wang XJ, Zhang HD, Sun XQ, Zhao QH, Wang L, He J, Jiang X, Liu JM, Jing ZC.

Eur Respir J. 2016 Nov;48(5):1386-1395. doi: 10.1183/13993003.00245-2016.

PMID:
27660508
17.

Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes.

Fender EA, Widmer RJ, Hodge DO, Cooper GM, Monahan KH, Peterson LA, Holmes DR Jr, Packer DL.

Circulation. 2016 Dec 6;134(23):1812-1821.

PMID:
27793993
18.

Capillary density: An important parameter in nailfold capillaroscopy.

Emrani Z, Karbalaie A, Fatemi A, Etehadtavakol M, Erlandsson BE.

Microvasc Res. 2016 Sep 7;109:7-18. doi: 10.1016/j.mvr.2016.09.001. [Epub ahead of print] Review.

PMID:
27614146
19.

Clinical Relevance of Computed Tomography Pulmonary Venography.

Braun SD, Platzek I, Danowski D, Zöphel K, Weise M, Kolditz M, Katzke S, Strasser RH, Höffken G, Halank M.

Heart Lung Circ. 2016 Dec;25(12):1154-1163. doi: 10.1016/j.hlc.2016.04.023. Review.

20.

Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study.

Huo Y, Jing ZC, Zeng XF, Liu JM, Yu ZX, Zhang GC, Li Y, Wang Y, Ji QS, Zhu P, Wu BX, Zheng Y, Wang PP, Li J.

BMC Cardiovasc Disord. 2016 Oct 22;16(1):201.

Items per page

Supplemental Content

Loading ...
Support Center